title: Perifosine-induced inhibition of Akt attenuates brain-derived neurotrophic factor/TrkB-induced chemoresistance in neuroblastoma in vivo.
abstract: BACKGROUND
  Neuroblastoma (NB) tumors expressing high levels of brain-derived neurotrophic factor (BDNF) and its receptor TrkB or activated Akt are associated with decreased event-free or overall survival in patients with NB. In the current study, the effect of perifosine, an Akt inhibitor, on the chemosensitivity of TrkB-expressing NB cells or tumors was evaluated.
  
  
  METHODS
  A tetracycline-regulated TrkB-expressing isogenic NB cell model system was tested. In this system, NB cells were treated with etoposide and/or perifosine both in vitro and in vivo. Inhibition of the target by perifosine was evaluated by Western blot analysis or kinase activity assay. Cell survival and tumor growth were investigated.
  
  
  RESULTS
  In vitro BDNF treatment induced Akt phosphorylation and rescued cells from etoposide-induced cell death in cells with high TrkB expression, but not in cells with low TrkB expression. Pretreatment of high TrkB-expressing TB3 cells with perifosine blocked BDNF/TrkB-induced Akt phosphorylation and inhibited BDNF's protection of TB3 cells from etoposide treatment. In vivo, tumors with high TrkB expression were found to have elevated levels of phosphorylated Akt and were less sensitive to etoposide treatment compared with tumors with low TrkB expression. Mice treated with a combination of perifosine and etoposide were found to have a statistically significant decrease in tumor growth compared with mice treated with either etoposide or perifosine alone. Activation of Akt through the BDNF/TrkB signaling pathway induced chemoresistance in NB in vivo.
  
  
  CONCLUSIONS
  Perifosine-induced inhibition of Akt increased the sensitivity of NB to chemotherapy. The results of the current study support the future clinical evaluation of an Akt inhibitor combined with cytotoxic drugs for the improvement of treatment efficacy.
authors: Cell and Molecular Biology Section, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. lizhijie@mail.nih.gov
authors: Zhijie
authors: Z
authors: Li
authors: Doo-Yi
authors: DY
authors: Oh
authors: Katsuya
authors: K
authors: Nakamura
authors: Carol J
authors: CJ
authors: Thiele
references: J Cell Physiol. 2006 Jul;208(1):220-8
references: 16575905
references: J Natl Cancer Inst. 2006 Sep 6;98(17):1193-203
references: 16954472
references: Nature. 2008 Oct 16;455(7215):975-8
references: 18923525
references: J Urol. 2009 Dec;182(6):2569-77
references: 19836781
references: Cancer Chemother Rep. 1966 May;50(4):219-44
references: 4957125
references: Nat Rev Cancer. 2003 Mar;3(3):203-16
references: 12612655
references: Cancer Res. 2005 Mar 15;65(6):2070-5
references: 15781614
references: J Clin Oncol. 1993 Aug;11(8):1466-77
references: 8336186
references: Mol Cell Biol. 1994 Jan;14(1):759-67
references: 8264643
references: J Natl Cancer Inst. 2010 Jun 2;102(11):747-9
references: 20463308
references: Carcinogenesis. 2008 Oct;29(10):1869-77
references: 18566016
references: N Engl J Med. 1993 Mar 25;328(12):847-54
references: 8441429
references: Cancer Res. 1996 Aug 15;56(16):3737-42
references: 8706017
references: Curr Top Med Chem. 2005;5(2):109-25
references: 15853641
references: Cancer Res. 1995 Apr 15;55(8):1798-806
references: 7712490
references: Ann Surg. 2002 May;235(5):621-9; discussion 629-30
references: 11981207
references: Cancer Res. 2002 Nov 15;62(22):6756-63
references: 12438277
references: Cancer Res. 2007 Jan 15;67(2):735-45
references: 17234785
references: Med Pediatr Oncol. 2001 Jan;36(1):181-4
references: 11464878
references: Mol Cancer Res. 2009 Nov;7(11):1813-21
references: 19887560
references: Mol Biol Cell. 2005 Jan;16(1):348-57
references: 15537704
references: J Natl Cancer Inst. 2010 Jun 2;102(11):758-70
references: 20463309
references: Cancer. 2011 Mar 15;117(6):1321-91
references: 20960503
references: J Cell Physiol. 2000 Jan;182(1):24-32
references: 10567913
references: Eur J Obstet Gynecol Reprod Biol. 2008 Nov;141(1):64-9
references: 18687514
references: Lancet. 2007 Jun 23;369(9579):2106-20
references: 17586306
references: J Clin Oncol. 1999 Jul;17(7):2264-79
references: 10561284
references: J Surg Res. 2005 Jul 1;127(1):21-8
references: 15882878
references: Invest New Drugs. 2006 Sep;24(5):435-9
references: 16528479
references: Clin Cancer Res. 2010 Mar 1;16(5):1478-85
references: 20179224